oral Archives - Good News!

PEOPLE WITH THE SKIN CONDITION KNOWN AS MODERATE-TO-SEVERE PLAQUE PSORIASIS NOW HAVE A NEW Rx TREATMENT OPTION

Austin Tang — Mon, 07 Nov 2022 20:57:05 +0000

Listen to “PEOPLE WITH THE SKIN CONDITION KNOWN AS MODERATE-TO-SEVERE PLAQUE PSORIASIS NOW HAVE A NEW Rx TREATMENT OPTION” on Spreaker.

The FDA Recently Approved a New Oral Treatment

There is now a new treatment option for the estimated 2 million people in the United States living with moderate-to-severe plaque psoriasis1,2,3 whose symptoms may make day-to-day life more challenging. For those that aren’t familiar with psoriasis, it is a widely prevalent, chronic, systemic immune-mediated disease.4

And up to 90% of patients with psoriasis have psoriasis vulgaris, also known as plaque psoriasis,5 which is characterized by distinct round or oval plaques typically covered by silvery-white scales.

One of the challenges that both doctors and patients face is that despite the availability of therapies, many people living with plaque psoriasis in the United States are untreated or undertreated.5,6

But good news has arrived. The U.S. Food and Drug Administration (FDA) has officially approved a new treatment for adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.

Dr. April Armstrong, dermatologist and clinical investigator in one of the treatment’s trials and Associate Dean and Professor of Dermatology at the University of Southern California, alongside Leah M. Howard, J.D., President and CEO of the National Psoriasis Foundation, will discuss the impact of psoriasis and a new, FDA-approved oral treatment for moderate-to-severe plaque psoriasis. *

*Dr. April Armstrong and Leah Howard are paid spokespeople and are being compensated for their time.

Interview is courtesy: Bristol Myers Squibb

1. Armstrong AW, Mehta MD, Schupp CW, Gondo GC, Bell SJ, Griffiths CEM. Psoriasis prevalence in adults in the United States. JAMA Dermatol.2021;157(8):940-946. doi:10.1001/jamadermatol.2021.2007

2 Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020;323(19):1945-1960. doi:10.1001/jama.2020.4006

3 Armstrong et al. Undertreatment, Treatment Trends, and Treatment Dissatisfaction Among Patients With Psoriasis and Psoriatic Arthritis in the United States: Findings From the National Psoriasis Foundation Surveys, 2003-2011. JAMA Dermatol. 2013;149(10):1180–1185.
4. Armstrong AW, Schupp C, Wu J, Bebo B. Quality of life and work productivity impairment among psoriasis patients: findings from the National Psoriasis Foundation survey data 2003–2011. PloS One. 2012;7(12):e52935.

5. Menter A, Gottlieb A, Feldman SR, Van Voorhees AS et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 2008 May;58(5):826-50.

6. Lebwohl M, Langley RG, Paul C, et al. Evolution of patient perceptions of psoriatic disease: results from the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) survey. Dermatol Ther (Heidelb). 2022;12(1):61-78. doi:10.1007/s13555-021-00635-4

#aprilarmstrong #leahhoward #plaquepsoriasis #psoriasis #treatment #immunedisease #prevalent #chronic #systemicdisease #clinicaltreatment

The post PEOPLE WITH THE SKIN CONDITION KNOWN AS MODERATE-TO-SEVERE PLAQUE PSORIASIS NOW HAVE A NEW Rx TREATMENT OPTION appeared first on Good News!.

Dental Health Crisis with Alison Corcoran EVP and Chief Marketing Officer, DentaQuest

Austin Tang — Sun, 05 Jan 2020 10:07:02 +0000

http://goodnewsplanet.com/wp-content/uploads/2020/01/alison_corcoran_1.mp3
DID YOU KNOW THAT THERE’S AN IMPORTANT LINK BETWEEN DENTALHEALTH AND YOUR OVERALL HEALTH?
BUT FOR TOO MANY AMERICANS – ABOUT 74 MILLION – A SIMPLETRIP TO THE DENTIST IS IMPOSSIBLE… BECAUSE THEY DON’T HAVE ACCESS TO ORALHEALTH CARE.
HERE TO TALK ABOUT GAPS IN THE ORAL HEALTH CARE SYSTEM AND WHAT CAN DONE ABOUT THEM, IS ALISON CORCORAN, EXECUTIVE VICE PRESIDENT AND CHIEF MARKETING OFFICER AT DENTAQUEST.
BIO-AlisonCorcoran
Executive Vice President and Chief Marketing Officer
Alison Corcoran is EVP and Chief Marketing Officer of DentaQuest, the nation’s leading organization dedicated to improving the oral health of all. Under her leadership, DentaQuest is transforming the model of care and achieving significant social impact.
Alison brings a powerful combination of future-forward strategies and deep marketing expertise to DentaQuest’s brand and business model. Through her efforts, DentaQuest is developing innovative, data-intensive approaches to elevate the patient experience and improve care overall.
As a passionate champion of progress, Alison also serves as President of the DentaQuest Partnership for Oral Health Advancement, which she helped establish. The Partnership addresses under invested areas of oral health that are critical to providing better care to more people. To date, the organization’s research and strategic grantmaking programs have provided more than $200 million in funding to improve oral health.
Prior to joining DentaQuest, Alison served in a number of senior leadership positions for national and international organizations including Staples, Sears Canada, and BJ’s Wholesale Club. Alison also founded Corcoran & Associates, a marketing and strategy firm providing consultancy services to companies such as Zipcar and The Princeton Review.
She received her Master of Business Administration (MBA)from the Tuck School at Dartmouth College and her Bachelor of Arts (BA) from Williams College.
Website DentaQuest.com
· Courtesy language: This interview is sponsored by DentaQuest.

The post Dental Health Crisis with Alison Corcoran EVP and Chief Marketing Officer, DentaQuest appeared first on Good News!.

Oral Health Expert Dr. Jonathan B. Levine and the GLO Good Foundation Partner with Oral-B®

editor — Sun, 10 Feb 2013 15:57:13 +0000

to Bring Healthy Smiles to Youth at Harlem Children’s Zone

Oral-B has teamed up with Dr. Jonathan B. Levine, nationally recognized NYC based oral health expert and regular contributor on “The Dr. Oz Show,” to help Americans improve their oral health. Through a charitable partnership, Oral-B and Dr. Levine’s GLO Good Foundation are educating Americans on the importance of having good oral health. They visited and will be visiting select areas throughout the country, starting right here in Harlem on January 24th.

Dr. Levine joined more than 300 kids (ages K-12) at the Harlem Children’s Zone to host a special themed event, “Brush Up Smile Zone!” The event included a variety of fun and educational activities that spread the message about the importance of good oral health –as it relates to overall health.

PLUS! Dr. Mehmet Oz, Emmy® Award-winning host of “The Dr. Oz Show,” made a special appearance supporting his colleague and very own dentist Dr. Levine, sharing the importance of this mission. Along with Geoffrey Canada, introducing Dr. Levine and Dr. Oz.

WHERE: Countee Cullen Community Center, PS 194

244 West 144th Street, New York, NY

Located between 7th Avenue (Frederick Douglass Blvd) and 8th Avenue (Adam Clayton Powell Jr. Blvd)

WHO: Dr. Jonathan B. Levine, Oral Health Expert

Dr. Mehmet Oz, host of “The Dr. Oz Show”

· Photos of Dr. Levine and Dr. Oz demonstrating oral health care tips via interactive presentation using props from “The Dr. Oz Show”

· Photos of more than 300 Harlem Children’s Zone kids participating in “Brush Up Smile Zone” activities, including:

Tooth [Photo] Booth

Plaque Attack Experiment

Brushing Bingo and more!

ABOUT ORAL-B: Oral-B is the worldwide leader in the over $5 billion brushing market and is working to help to raise nationwide awareness of the importance of having a healthy mouth. Part of the Procter & Gamble Company, the brand includes manual and power toothbrushes for children and adults, oral irrigators and interdental products, such as dental floss. Through its work with Dr. Jonathan B. Levine, Oral-B is encouraging Americans to take control of their oral health, and helping to educate them on the relationship between oral health and overall health. For more information, visit OralB.comor Facebook.com/OralB.

ABOUT GLO GOOD FOUNDATION: The GLO GOOD foundation is a nonprofit organization founded by Dr. Jonathan B. Levine and his business partner and wife Stacey Levine, GLO Science founder, to build oral health initiatives in underserved populations globally. GLO GOOD creates comprehensive initiatives around oral health education, conducts screenings, delivers dental care and develops products that give people the tools to promote good oral health. The mission of the foundation is to make all people smile, and for good oral health to be available to everyone. To learn more about GLO GOOD, the founders and the GLO mission, visit: www.gloscience.com/glogood

ABOUT HARLEM CHILDREN’S ZONE:

The nonprofit Harlem Children’s Zone serves more than 11,000 children – from birth through college – and their families through a comprehensive network of education, social-service and community-building programs. The agency’s goal is to break the intergenerational cycle of poverty through education.

The post Oral Health Expert Dr. Jonathan B. Levine and the GLO Good Foundation Partner with Oral-B® appeared first on Good News!.